Access neurosurgical experts for decision support—on demand with the CNS and Nidus!
The CNS is excited to announce a new collaboration with Nidus to help our members and patients make better-informed decisions together.
Complex neurosurgical conditions often pose difficult choices between different treatment options. Nidus was founded by neurosurgeons and clinical researchers to facilitate making the right decisions about surgery and surgical approach for the best patient outcome. The Nidus medical advisory board is comprised of current and past CNS leaders such as Zoher Ghogawala, Steven Kalkanis, Daniel Resnick, Douglas Kondziolka, Sepi Amin-Hanjani, and Edward Benzel. The Nidus concept emerged from the clear advantage of having multiple expert opinions from a panel of experienced specialists. Today, Nidus enables you to obtain a virtual consult with an international panel of experts—all within 72 hours. The benefit to you and your patients is the confidence that comes with this decision-support tool in choosing the best management.
CNS-Nidus November Case Spotlight
Case Summary: 51 year-old male with 6 week history of headache and now expressive aphasia - Lives in Egypt and is in hospital on steroids and keppra. Family looking for information on best local options for treatment. They have been told that intraoperative MRI and awake surgery would be the best option in London.
Recommendation (12 Brain Tumor Experts): A significant majority of surgeons favor gross total resection of contrast enhancing areas. In consideration of special technologies, a majority recommend considering navigation, collecting tissue for clinical trial, an awake craniotomy, and functional/white matter mapping.
Brain Tumor Experts Who Contributed to Review:
E. Antonio Chiocca, Brigham and Women's Hospital
Michael Vogelbaum, Moffitt Cancer Center
Allan Friedman, Duke University, Durham
Steven Kalkanis, Henry Ford Health System
Basant Misra, Hinuja National Hospital & Medical Research Center
Brain Tumor Conference, Lahey Hospital & Medical Center
Daniel P. Cahill, Massachusetts General Hospital
Julian K Wu, Tufts Medical Center
Linda M Liau, University of California
Francesco DiMeco, Foundation IRCCS Carlo Besta Neurological Institute
Frederick Lang, University of Texas MD Anderson Cancer Center
What is Nidus?
Nidus is a web-based platform that virtually connects CNS members and their patients with a global network of neurosurgical expertise and clinical research.
How does Nidus work?
Nidus is an easy-to-use application that allows a neurosurgeon or patient to create a brief case synopsis with clinical history and imaging. The case synopsis is transmitted virtually to the Nidus panel of neurosurgical specialists for review and individual expert opinion. Nidus analyzes the panel recommendations using a machine-learning algorithm built from a large patient database, and presents a customized, concise summary.
Nidus access includes:
- Personalized case building (patient history, imaging)
- Analysis and review from a panel of specialists
- Expert opinions and recommendations based on clinical research and data analytics from an expansive patient outcomes registry
Want more information? Download the Nidus brochure or visit the Nidus website by clicking "Learn More" below.
Disclaimer: This website, cns.org, is maintained and operated by the Congress of Neurological Surgeons (“CNS”) and contains links to other sites and resources provided by third parties, including but not limited to those owned and operated by GN2.0-Nidus, Inc. and its affiliates (“Nidus”). Any information on the CNS website related to Nidus is being provided strictly for informational purposes only. Any links to any third party website (including but not limited to the Nidus website) are provided for your convenience only. We have no control over the contents of those sites or resources, and accept no responsibility for them or for any loss or damage that may arise from your use of them. If you decide to access any of the third-party websites linked from or to this website, you do so entirely at your own risk and subject to the terms and conditions of use for such websites.